Media headlines about InfuSystem Holdings (NYSE:INFU) have been trending somewhat positive recently, according to Accern Sentiment. Accern scores the sentiment of press coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. InfuSystem Holdings earned a media sentiment score of 0.09 on Accern’s scale. Accern also gave news stories about the medical instruments supplier an impact score of 45.9198966244768 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Here are some of the media headlines that may have impacted Accern Sentiment Analysis’s rankings:

InfuSystem Holdings (INFU) traded up 2.63% during midday trading on Friday, reaching $1.95. 2,352 shares of the company’s stock traded hands. The stock’s 50 day moving average price is $1.84 and its 200-day moving average price is $1.92. The stock’s market cap is $44.37 million. InfuSystem Holdings has a one year low of $1.20 and a one year high of $3.04.

InfuSystem Holdings (NYSE:INFU) last posted its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported ($0.02) earnings per share for the quarter. InfuSystem Holdings had a negative net margin of 8.37% and a negative return on equity of 11.82%. The company had revenue of $16.94 million for the quarter. Equities analysts predict that InfuSystem Holdings will post $0.24 earnings per share for the current year.

In related news, Director Darrell B. Montgomery acquired 25,000 shares of the stock in a transaction dated Monday, August 14th. The shares were purchased at an average cost of $1.88 per share, with a total value of $47,000.00. Following the transaction, the director now directly owns 12,000 shares in the company, valued at $22,560. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Meridian Ohc Partners, Lp acquired 56,670 shares of the stock in a transaction dated Wednesday, August 16th. The shares were bought at an average cost of $1.84 per share, for a total transaction of $104,272.80. The disclosure for this purchase can be found here. Over the last ninety days, insiders have bought 181,156 shares of company stock worth $335,967.

TRADEMARK VIOLATION NOTICE: “Somewhat Positive News Coverage Somewhat Unlikely to Impact InfuSystem Holdings (INFU) Stock Price” was first reported by Watch List News and is the sole property of of Watch List News. If you are viewing this piece of content on another publication, it was illegally copied and reposted in violation of US & international copyright and trademark law. The legal version of this piece of content can be viewed at

About InfuSystem Holdings

InfuSystem Holdings, Inc is a provider of infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers and other sites of care. The Company delivers local, field-based customer support and also operates pump service and repair Centers of Excellence in Michigan, Kansas, California, Texas and Ontario, Canada.

Insider Buying and Selling by Quarter for InfuSystem Holdings (NYSE:INFU)

Receive News & Ratings for InfuSystem Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem Holdings Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.